// SECTOR DOSSIER
synthetic biology Unicorns
Every synthetic biology unicorn we track — 2 private companies valued $1B or more, tiered by paper valuation. Combined balance sheet myth: $30B.
TIER 2 // PRIORITY TARGETS
The Decacorns $10B – $99B · 1
TIER 3 // STANDING HORDE